
欧洲皮下注射针市场预测至 2028 年 - COVID-19 影响和区域分析(按类型(安全针和非安全针)、应用(药物输送、疫苗接种和血液样本采集)、最终用户(诊断中心、医院和诊所和家庭保健)和用途(一次性和可重复使用)
No. of Pages: 135 | Report Code: TIPRE00026209 | Category: Life Sciences
No. of Pages: 135 | Report Code: TIPRE00026209 | Category: Life Sciences
由于血源性感染的高流行等驱动因素,预计安全针头市场将在预测期内增长疾病、政府积极参与实施严格的法规、注射药物和药物的需求增加疫苗和新兴经济体尚未开发的潜力。然而,安全针头和替代药物输送选择的高成本预计将阻碍预测期内的市场增长。
此外,疫苗需求的激增预计将推动预测期内的市场增长.
COVID-19 大流行需要快速开发疫苗来控制该疾病。大多数疫苗接种,包括目前批准用于 COVID-19 的疫苗接种,都是使用皮下注射针进行肌肉注射和皮下注射。同样,2021 年 3 月,康泰伦特扩大了与强生公司的合作伙伴关系。约翰逊将大幅提高意大利 COVID-19 疫苗的无菌生产和包装能力。 Catalent 宣布 Catalent Biologics 将大幅提高 Catalent 位于意大利阿纳尼的制造工厂大规模商业供应杨森 COVID-19 疫苗的生产能力。因此,欧洲皮下注射针头市场受到了 COVID-19 的积极影响。
欧洲皮下注射针头市场预计将从 2021 年的 9.858 亿美元增至 2028 年的 15.029 亿美元。预计从 2021 年到 2028 年,该市场将以 6.2% 的复合年增长率增长。皮下注射针头市场的制造商正在提高精密设计的针头和针刺预防技术的可用性,以在具有挑战性的应用中脱颖而出。公司正在提供安全的设计和较少痛苦的注射,以确保治疗成功。皮下注射针正在接受受控制造和严格检查,以确保质量,以应对无针注射器的竞争。例如,2021年4月,三泽医疗工业株式会社推出了“低死腔针”,以减少注射器内残留的药液量。这减少了死腔,即液体保留在注射器中而无需使用特殊注射器,从而减少了治疗药物的浪费。
从类型来看,2020年安全针头细分市场占据欧洲皮下注射针市场最大份额;从应用来看,给药细分市场占据欧洲皮下注射针市场最大份额2020年。就最终用户而言,医院细分市场在2020年欧洲皮下注射针市场中占据最大份额。此外,根据使用情况,一次性细分市场在2020年占据最大市场份额。
准备本皮下注射针头报告时参考的一些主要一手和二手来源欧洲市场包括公司网站、年度报告、财务报告、国家政府文件、统计数据库等。报告中列出的主要公司包括 Terumo Corporation、BD、B. Braun Melsungen AG、Catalent Inc.、Cardinal Health Inc.、Vygon 和 Barber of Sheffield。
按类型
按申请
最终用户
按使用
< ul>按国家/地区 p>
Strategic insights for Europe Hypodermic Needles involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 985.8 Million |
Market Size by 2028 | US$ 1502.9 Million |
Global CAGR (2021 - 2028) | 6.2% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By 类型
|
Regions and Countries Covered | 欧洲
|
Market leaders and key company profiles |
The regional scope of Europe Hypodermic Needles refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Europe Hypodermic Needles Market is valued at US$ 985.8 Million in 2021, it is projected to reach US$ 1502.9 Million by 2028.
As per our report Europe Hypodermic Needles Market, the market size is valued at US$ 985.8 Million in 2021, projecting it to reach US$ 1502.9 Million by 2028. This translates to a CAGR of approximately 6.2% during the forecast period.
The Europe Hypodermic Needles Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Hypodermic Needles Market report:
The Europe Hypodermic Needles Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Hypodermic Needles Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Hypodermic Needles Market value chain can benefit from the information contained in a comprehensive market report.